- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03978468
ICOLLAB FOR Children With Medical Complexity (ICOLLAB)
Interagency Collaboration To Improve Home Care of Children With Medical Complexity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The specific aims of this study are to: develop and implement a model of care, Interagency Collaboration (ICollab) in which communication with Home Health Nurse (HHN) and Primary Care Provider (PCP) is maintained and clinical support is provided to HHN; evaluate whether ICollab is effective in reducing healthcare utilization of Children with medical complexity (CMC) and caregiver burden; and assess caregiver satisfaction in home health care, HHN retention, and collaboration with other healthcare providers.
Methods: Investigators will develop and implement an intervention model (ICollab) that includes: (1) maintaining communication with HHN and PCP about clinical information about CMC, and (2) providing clinical support to HHN. Investigators will create an interdisciplinary intervention team in our children s hospital consisting of a pediatrician and a nurse. The intervention team will ensure communication with HHN and PCP by communicating clinical information (recommendations from clinic visits and emergency room (ER) visits, and discharge summary). The team will provide clinical support to HHN via collaborative meetings and availability as a resource for clinical problem-solving with HHN. Investigators will recruit 110 CMC discharged home on private-duty nursing services into this randomized trial. The intervention group (n=55) will receive the ICollab intervention for 6 months post-discharge from the hospital, in addition to usual care. Children in the control group (n=55) will receive only usual care. Outcome measures will include healthcare utilization metrics (hospitalization rates, ER visit rates, and days to readmission), caregiver burden and caregiver satisfaction with home health care, HHN retention, and HHN collaboration with other healthcare providers. Investigators hypothesize that ICollab will reduce healthcare utilization and caregiver burden, and improve caregiver satisfaction with home health care, increase HHN retention, and increase HHN collaboration with other healthcare providers. Investigators will perform a systematic process evaluation of the implementation of the intervention and standardize the ICollab model.
Implications: How healthcare delivery of CMC can be structured to avoid fragmentation especially surrounding transition across clinical settings is an understudied area. Our results will address this gap by providing a critically needed evidence-base for interventions to improve the quality of healthcare delivery for CMC
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Savithri Nageswaran, MD
- Phone Number: 336-716-6508
- Email: snageswa@wakehealth.edu
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The Nurse Clinician will screen children for eligibility for the study (see Eligibility Form). Only children with medical complexity (CMC) who are discharged home with private-duty nursing (PDN) services will be included. CMC will be identified as (1) child <18 years of age; and (2) presence of a chronic condition, defined as a health condition expected to last ≥ 12 months; and (3) complexity of the condition, defined as needing ongoing care with ≥ 5 sub-specialists/ services, or dependent on ≥ 2 technologies (e.g. gastrostomy, oxygen, tracheostomy, ventilator, etc.).
Exclusion Criteria:
- Children who might turn 18 during the intervention period will be excluded to avoid having to re-consent with adult informed consent form (ICF). Children who receive skilled nursing visits or personal care services only, those discharged to a long-term care facility or to a foster home, or whose caregivers do not speak English/Spanish, will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Usual Care Group
Children will receive usual care.
|
The primary medical team identifies the need for home health nursing services for Children with Medical Complexity(CMC), and the hospital care coordinators help caregivers choose a home health agency.
Hospital-based physicians write home health orders that are communicated to the home health agency.
The clinic manager of the home health agency uses these orders to develop the home health plan of care, Centers for Medicare & Medicaid Services(Form CMS-485) and communicates the plan to the agencies' HHNs.
PCPs oversee the home health plan of care.
|
Experimental: Interagency Collaboration (ICollab Group)
Subjects of this arm will receive ICollab intervention in addition to usual care which consists of communication with Home Health Nurse (HHN) , Collaborative meetings, and communication with Primary Care Physician (PCP)
|
The primary medical team identifies the need for home health nursing services for Children with Medical Complexity(CMC), and the hospital care coordinators help caregivers choose a home health agency.
Hospital-based physicians write home health orders that are communicated to the home health agency.
The clinic manager of the home health agency uses these orders to develop the home health plan of care, Centers for Medicare & Medicaid Services(Form CMS-485) and communicates the plan to the agencies' HHNs.
PCPs oversee the home health plan of care.
The intervention has the following components: 1) ICollab Component 1: The Nurse Clinician will review clinic and emergency room (ER) visit notes for clinicians' recommendations and communicate these to the home health nurse (HHN).
2) ICollab Component 2a: The intervention team will meet weekly by phone with HHNs (6 times/ child).
The Nurse Clinician will document meeting notes for each child in the ER, communicate this information with the HHN, and share it with the primary care provider (PCP) by routing the note through the ER or faxing the note.
3) ICollab Component 2b: The Nurse Clinician will be available as a resource for the HHN during regular work hours for clinical problem-solving.
4) ICollab Component 2c: the intervention team physician will offer her contact information for clinical problem-solving about the child to the PCP.
The Nurse Clinician will communicate with the PCP about the plan developed in the meetings, and changes to plan of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Hospitalization
Time Frame: 6 months
|
Using data obtained from the Translational Data Warehouse, the number of hospitalizations will be calculated for each child..compare the rate of hospitalizations/ 100-child years in the 2 groups. Number of hospitalizations during the observation period will be counted and the rate will be calculated as: [Number of hospitalizations/ observation period in years] *100 |
6 months
|
Rate of ER visits
Time Frame: 6 months
|
Rate of ER visits will be calculated as follows: [Number of ER visits/ observation period in years]*100
|
6 months
|
Days to readmission
Time Frame: 6 months
|
Days to readmission will be calculated as the duration between the time of index hospitalization (time of enrollment) and the date of admission for the subsequent hospitalization.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact on Family Scale
Time Frame: 6 months
|
Change in caregiver burden will be measured using the 15- item Impact on Family Scale - Revised, which has 4 domains - financial, family/ social, personal strain, and mastery.
Scores range from 15 to 60; the lower the score, the greater the impact.
|
6 months
|
Client Satisfaction Survey
Time Frame: 6 months
|
Caregiver satisfaction with home care will be compared between the 2 groups and measured by the Client Satisfaction Survey.
It has 35 items with 4 subscales.
Total Score: Minimum 1 and Maximum 5; lower the score the better
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Home health nurse retention
Time Frame: 6 months
|
Staff retention will be measured as turnover rate using data from monthly caregiver surveys.
[Average monthly HHN separations/average number of HHN assigned to the case] *100
|
6 months
|
Home health nurse-healthcare provider collaborations, HHN PCP ICOLLAB Survey
Time Frame: 6 months
|
Caregiver perception of collaboration between HHN and other healthcare providers at the end of the study period will be compared for the 2 groups.
HHN PCP ICOLLAB Survey.
Qualitative data analysis methods will be used
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Savithri Nageswaran, MD, Wake Forest University Health Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00058144
- 10359 (Other Identifier: Fred Hutch/University of Washington Cancer Consortium)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children With Medical Complexity
-
Wake Forest University Health SciencesPatient-Centered Outcomes Research InstituteNot yet recruitingChildren With Medical ComplexityUnited States
-
NYU Langone HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingChildren With Medical Complexity (CMC)United States
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)RecruitingChildren and Youth With Medical ComplexityCanada
-
The Hospital for Sick ChildrenChildren's Hospital of Eastern Ontario; Montreal Children's Hospital of the...CompletedMedical Education | Children With Medical Complexity | Complex Care | Pediatric ResidentsCanada
-
The Hospital for Sick ChildrenHamilton Health Sciences Corporation; London Health Sciences Centre; Children...Completed
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingEmpowerment | Children With Medical Complexity | Invasive Mechanical Ventilation | Home NursingUnited States
-
University of UtahHRSA/Maternal and Child Health BureauCompletedChildren With Medical ComplexityUnited States
-
University of UtahChildren's Hospital Los AngelesRecruitingMultiple Chronic Conditions | Children With Medical ComplexityUnited States
-
University of Wisconsin, MadisonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedCOVID-19 | Children With Medical Complexity (CMC)United States
-
University of Wisconsin, MadisonEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingCOVID-19 | Children With Medical Complexity (CMC)United States
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Centers for Disease Control and PreventionCompleted
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
The Miriam HospitalNational Institute on Aging (NIA)RecruitingHeart FailureUnited States
-
Lawson Health Research InstituteUnknownDepression | Quality of Life | Sleep | Anxiety | Dry EyeCanada
-
U.S. Wound RegistryRecruitingWounds and Injuries | Diabetic Foot | Leg Ulcer | Skin Ulcer | Diabetes Complications | Diabetic Neuropathies | Lymphedema | Peripheral Arterial Disease | Vasculitis | Venous Insufficiency | Varicose Ulcer | Pressure Ulcer | Pyoderma | Surgical Wound Dehiscence | Amputation StumpUnited States
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of